创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: ELISA Platform Enables Precision Life Science Research

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-02 14:14
  • Views:

(Summary description)InnoModels Biotechnology has once again launched the ELISA (Enzyme-linked Immunosorbent Assay) platform, an important tool for leading scientific innovation, providing researchers with an efficient, accurate and sensitive tool for life science research.The excellent performance of the ELISA platform will vigorously promote the progress of the biomedical field, and provide reliable support for the diagnosis and treatment of diseases and the development of new drugs.

InnoModels Biotechnology: ELISA Platform Enables Precision Life Science Research

(Summary description)InnoModels Biotechnology has once again launched the ELISA (Enzyme-linked Immunosorbent Assay) platform, an important tool for leading scientific innovation, providing researchers with an efficient, accurate and sensitive tool for life science research.The excellent performance of the ELISA platform will vigorously promote the progress of the biomedical field, and provide reliable support for the diagnosis and treatment of diseases and the development of new drugs.

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-02 14:14
  • Views:
Information

InnoModels Biotechnology has once again launched the ELISA (Enzyme-linked Immunosorbent Assay) platform, an important tool for leading scientific innovation, providing researchers with an efficient, accurate and sensitive tool for life science research.The excellent performance of the ELISA platform will vigorously promote the progress of the biomedical field, and provide reliable support for the diagnosis and treatment of diseases and the development of new drugs.
Technical features of ELISA platform
1. High sensitivity and precision:
The ELISA platform utilizes advanced optical detection technology and high quality antibodies to ensure highly sensitive detection of trace biomolecules. Its accuracy enables researchers to accurately determine the content of target molecules in biological samples, providing a reliable data base for life science research.
2. Diverse detection targets:
The ELISA platform is widely applicable to the detection of a wide range of biomolecules, including proteins, antibodies, hormones and so on. Researchers can choose the appropriate ELISA kits according to their research needs, realizing rapid and accurate detection of different biomarkers and providing support for a wide range of research fields.
3. Flexibility and scalability:
ELISA platform has flexible operation flow and scalable detection range, which is suitable for small-scale research experiments to large-scale high-throughput screening. This flexibility makes the ELISA platform ideal for a wide range of research needs and provides researchers with greater freedom in experimental design.
4. Automation and high throughput:
The ELISA platform combines advanced automation technology to enable high-throughput biomolecule detection. Automation greatly improves the efficiency of experiments and reduces human errors, allowing researchers to focus on the interpretation of results and data analysis.

 


5. User-friendly data analysis software:
The platform is equipped with user-friendly data analysis software that enables researchers to easily access, interpret and share experimental data. This feature further lowers the threshold of use and enables more researchers to fully utilize the ELISA platform for efficient experimental design and data interpretation.
Research Applications and Future Prospects
1. Disease marker research:
ELISA platform has important application value in disease marker research, which can help researchers screen potential biomarkers quickly and accurately, and provide powerful support for early diagnosis and treatment of diseases.
2. Drug development and pharmacodynamics research:
In drug development and pharmacodynamics research, ELISA platform can be used to evaluate the effects of drugs on biomolecules, providing reliable data support for new drug development.
3. Basic biological research:
ELISA platforms are not only suitable for clinical applications, but also have a wide range of applications in basic biological research, providing an important tool for researchers to gain a deeper understanding of the expression and function of biomolecules.
Conclusion
With its excellent technical features, the ELISA platform from InnoModels Biotechnology will become an indispensable tool in the field of life science research. With its wide application in various fields, the ELISA platform is expected to further promote the development of scientific research and contribute more to human health and medical progress.

Keyword:

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司